.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cipla
Mallinckrodt
Moodys
Express Scripts
Citi
Accenture
US Department of Justice
QuintilesIMS
Deloitte

Generated: December 15, 2017

DrugPatentWatch Database Preview

Technetium tc-99m sestamibi kit - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for technetium tc-99m sestamibi kit and what is the scope of technetium tc-99m sestamibi kit freedom to operate?

Technetium tc-99m sestamibi kit
is the generic ingredient in four branded drugs marketed by Lantheus Medcl, Cardinal Health 414, Jubilant Draximage, Pharmalucence, and Mallinkrodt Nuclear, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m sestamibi kit. Five suppliers are listed for this compound.

Summary for technetium tc-99m sestamibi kit

Pharmacology for technetium tc-99m sestamibi kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Lantheus MedclCARDIOLITEtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-001Dec 21, 1990APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Cardinal Health 414TECHNETIUM TC 99M SESTAMIBItechnetium tc-99m sestamibi kitINJECTABLE;INJECTION078809-001Apr 28, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PharmalucenceTECHNETIUM TC 99M SESTAMIBItechnetium tc-99m sestamibi kitINJECTABLE;INJECTION079157-001Jul 10, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mallinkrodt NuclearTECHNETIUM TC-99M SESTAMIBItechnetium tc-99m sestamibi kitINJECTABLE;INJECTION078098-001Sep 22, 2008APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lantheus MedclMIRALUMAtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-003May 23, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Jubilant DraximageTECHNETIUM TC 99M SESTAMIBItechnetium tc-99m sestamibi kitINJECTABLE;INJECTION078806-001Apr 29, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: technetium tc-99m sestamibi kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus MedclMIRALUMAtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-003May 23, 1997► Subscribe► Subscribe
Lantheus MedclCARDIOLITEtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
Lantheus MedclMIRALUMAtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-003May 23, 1997► Subscribe► Subscribe
Lantheus MedclMIRALUMAtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-003May 23, 1997► Subscribe► Subscribe
Lantheus MedclMIRALUMAtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-003May 23, 1997► Subscribe► Subscribe
Lantheus MedclCARDIOLITEtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
Lantheus MedclMIRALUMAtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-003May 23, 1997► Subscribe► Subscribe
Lantheus MedclCARDIOLITEtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
Lantheus MedclCARDIOLITEtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
Lantheus MedclCARDIOLITEtechnetium tc-99m sestamibi kitINJECTABLE;INJECTION019785-001Dec 21, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Novartis
Fuji
Farmers Insurance
Teva
US Department of Justice
AstraZeneca
Harvard Business School
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot